Home / Publication / Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

論文

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Author(s): Mohamed Elmeliegy, Joseph Chen, Aruna Dontabhaktuni, Allison Gaudy, Georgi I. Kapitanov, Junyi Li, Sabiha R. Mim, Sharad Sharma, Qin Sun, Sihem Ait-Oudhia

Year: 2024年7月4日

How Model-informed drug development rescue projects from a risky situation

事例紹介

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

ポスター

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

論文

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

ポスター

Powered by Translations.com GlobalLink Web Software

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

How Model-informed drug development rescue projects from a risky situation

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

How Model-informed drug development rescue projects from a risky situation​

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

メルマガ登録

クイックアクセス

ソリューション

お問合せ

How Model-informed drug development rescue projects from a risky situation